menu
    • menu

    Company profile for Corium

    NEW Drugs in Dev: 3
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Corium is a commercial-stage biopharmaceutical company leading the development and commercialization of novel neuroscience therapies that provide clinicians with important treatment options for patients, their families, and their caregivers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CoriumUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11 Farnsworth Street 4th Floor Boston, MA 02210
    Telephone
    Telephone
    650.298.8255
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://corium.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Collegium Acquiring AZSTARYS From Corium To Boost ADHD Position
    Collegium Acquiring AZSTARYS From Corium To Boost ADHD Position

    19 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/19/3258918/34897/en/Collegium-to-Acquire-AZSTARYS-from-Corium-Therapeutics-Strengthening-Position-in-ADHD-and-Accelerating-Growth-Trajectory.html

    GLOBENEWSWIRE
    19 Mar 2026
    Share Share
    Corium Announces Publication of Favorable ADLARITY Skin Irritation Trial Data
    Corium Announces Publication of Favorable ADLARITY Skin Irritation Trial Data

    12 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/corium-announces-publication-of-favorable-adlarity-donepezil-transdermal-system-skin-irritation-clinical-trial-data-301924112.html

    PR NEWSWIRE
    12 Sep 2023
    Share Share
    Corium, Lotus Pharmaceutical Partner on Alzheimer's Drug Adlarity
    Corium, Lotus Pharmaceutical Partner on Alzheimer's Drug Adlarity

    10 Aug 2023

    // CONTRACT PHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2023-08-10/corium-lotus-pharmaceutical-partner-on-alzheimer-s/?widget=listSection

    CONTRACT PHARMA
    10 Aug 2023
    Share Share
    Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement
    Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement

    10 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230810982376/en

    BUSINESSWIRE
    10 Aug 2023
    Share Share
    Corium's Medication AZSTARYS Had No Significant Impact on Children's Weight
    Corium's Medication AZSTARYS Had No Significant Impact on Children's Weight

    22 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/coriums-novel-adhd-medication-azstarys-serdexmethylphenidate-and-dexmethylphenidate-had-no-clinically-significant-impact-on-childrens-weight-and-height-growth-rate-301830739.html

    PR NEWSWIRE
    22 May 2023
    Share Share
    Corium Pharma Solutions Names Suzanne Hinchliffe as Chief People Officer
    Corium Pharma Solutions Names Suzanne Hinchliffe as Chief People Officer

    01 Mar 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/corium-pharma-solutions-names-suzanne-hinchliffe-as-chief-people-officer-301758988.html

    PR NEWSWIRE
    01 Mar 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search